Healthcare Sector Stocks
The Healthcare sector has a total of 1052 stocks, with a combined market cap of $9.6 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 51.00.
Market Cap
9.6T
Revenue
4.67T
Profits
188.19B
PE Ratio
51.00
Profit Margin
4.03%
Dividend Yield
0.38%
1051 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.13T | -1.01% | 1,863,420 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 621.22B | -0.61% | 6,148,861 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 503.28B | -1.48% | 4,391,695 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 374.30B | -0.54% | 3,971,739 | 450.06B |
| 5 | MRK | Merck & Co., Inc. | 369.78B | 1.07% | 9,005,643 | 66.57B |
| 6 | NVS | Novartis AG | 292.87B | 0.19% | 1,019,041 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 261.47B | -0.22% | 1,896,807 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 256.61B | 0.97% | 4,044,123 | 47.35B |
| 9 | AMGN | Amgen Inc. | 236.98B | -0.14% | 2,610,230 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 190.42B | -1.88% | 6,179,367 | 30.46B |
| 11 | ABT | Abbott Laboratories | 173.92B | -1.89% | 22,906,016 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 173.82B | -0.74% | 6,812,368 | 50.34B |
| 13 | PFE | Pfizer Inc. | 170.14B | -0.86% | 22,197,428 | 63.70B |
| 14 | DHR | Danaher Corporation | 164.40B | 4.29% | 8,794,488 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 151.25B | -2.26% | 4,797,076 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 132.95B | 1.92% | 1,448,535 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 124.85B | -0.91% | 9,015,727 | 49.19B |
| 18 | CVS | CVS Health Corporation | 119.52B | -1.37% | 6,522,812 | 412.65B |
| 19 | MCK | McKesson Corporation | 118.40B | -1.42% | 772,066 | 410.98B |
| 20 | SYK | Stryker Corporation | 114.15B | -2.23% | 2,406,176 | 25.84B |
| 21 | MDT | Medtronic plc | 113.88B | -1.69% | 11,506,421 | 37.54B |
| 22 | HCA | HCA Healthcare, Inc. | 99.46B | -1.36% | 783,104 | 78.01B |
| 23 | GSK | GSK plc | 99.05B | -1.20% | 3,364,136 | 44.05B |
| 24 | MRNA | Moderna, Inc. | 98.14B | 1.54% | 16,130,497 | 2.23B |
| 25 | SNY | Sanofi | 97.89B | -1.04% | 3,110,520 | 55.89B |
| 26 | ELV | Elevance Health, Inc. | 94.15B | -1.37% | 2,474,568 | 201.83B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 80.45B | -0.22% | 581,034 | 15.53B |
| 28 | CI | The Cigna Group | 80.43B | -0.73% | 1,297,865 | 282.38B |
| 29 | COR | Cencora, Inc. | 64.96B | -0.83% | 1,514,585 | 332.77B |
| 30 | BSX | Boston Scientific Corporation | 64.51B | -2.35% | 15,186,501 | 21.00B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 63.32B | -0.75% | 1,671,347 | 28.42B |
| 32 | CAH | Cardinal Health, Inc. | 59.62B | -0.03% | 1,586,014 | 254.25B |
| 33 | NTRA | Natera, Inc. | 59.59B | 1.84% | 1,282,512 | 2.71B |
| 34 | ARGX | argenx SE | 56.49B | 2.34% | 656,462 | 5.32B |
| 35 | BDX | Becton, Dickinson and Company | 52.94B | 0.28% | 1,074,333 | 22.48B |
| 36 | VEEV | Veeva Systems Inc. | 51.90B | 0.59% | 1,430,993 | 3.46B |
| 37 | HUM | Humana Inc. | 51.08B | -0.46% | 1,542,105 | 145.68B |
| 38 | EW | Edwards Lifesciences Corporation | 50.95B | 0.12% | 2,717,009 | 6.51B |
| 39 | A | Agilent Technologies, Inc. | 50.11B | 2.74% | 2,135,422 | 7.37B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 47.33B | -0.56% | 4,593,620 | 17.32B |
| 41 | MDLN | Medline Inc. | 46.42B | -0.42% | 8,392,396 | 29.94B |
| 42 | IQV | IQVIA Holdings Inc. | 45.53B | 3.28% | 1,755,863 | 16.98B |
| 43 | WAT | Waters Corporation | 44.95B | 3.31% | 952,388 | 4.64B |
| 44 | ONC | BeOne Medicines AG | 43.94B | 0.51% | 571,718 | 6.13B |
| 45 | IDXX | IDEXX Laboratories, Inc. | 43.60B | -0.80% | 405,434 | 4.55B |
| 46 | HLN | Haleon plc | 43.31B | -1.47% | 13,006,389 | 14.80B |
| 47 | ILMN | Illumina, Inc. | 42.71B | 5.57% | 2,266,779 | 4.49B |
| 48 | RVMD | Revolution Medicines, Inc. | 41.64B | -1.15% | 1,847,941 | - |
| 49 | RPRX | Royalty Pharma plc | 35.74B | -0.16% | 2,741,940 | 2.54B |
| 50 | BIIB | Biogen Inc. | 35.61B | -0.87% | 812,841 | 10.03B |
| 51 | CNC | Centene Corporation | 34.70B | -0.80% | 3,047,940 | 180.30B |
| 52 | RMD | ResMed Inc. | 34.63B | 0.29% | 873,492 | 5.65B |
| 53 | MTD | Mettler-Toledo International Inc. | 33.62B | 2.69% | 140,295 | 4.13B |
| 54 | ZTS | Zoetis Inc. | 32.90B | -0.52% | 3,037,066 | 9.53B |
| 55 | ALC | Alcon Inc. | 32.57B | -0.59% | 1,103,654 | 10.86B |
| 56 | GEHC | GE HealthCare Technologies Inc. | 31.17B | -1.74% | 2,180,032 | 21.27B |
| 57 | DXCM | DexCom, Inc. | 30.29B | -6.39% | 8,017,811 | 4.97B |
| 58 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.12B | -2.43% | 1,177,498 | 4.80B |
| 59 | WST | West Pharmaceutical Services, Inc. | 27.69B | 1.21% | 573,644 | 3.33B |
| 60 | ROIV | Roivant Sciences Ltd. | 26.58B | 5.38% | 16,839,635 | 7.53M |
| 61 | DGX | Quest Diagnostics Incorporated | 26.37B | 0.76% | 1,205,022 | 11.56B |
| 62 | LH | Labcorp Holdings Inc. | 26.26B | 0.19% | 566,721 | 14.35B |
| 63 | PHG | Koninklijke Philips N.V. | 25.91B | 0.88% | 938,930 | 20.18B |
| 64 | UTHR | United Therapeutics Corporation | 24.17B | 1.74% | 440,535 | 3.15B |
| 65 | GMAB | Genmab A/S | 23.81B | 1.28% | 3,102,883 | 4.13B |
| 66 | INCY | Incyte Corporation | 22.99B | -2.72% | 1,385,663 | 5.82B |
| 67 | BNTX | BioNTech SE | 22.93B | 0.13% | 1,113,474 | 3.03B |
| 68 | GH | Guardant Health, Inc. | 22.37B | 2.50% | 2,521,960 | 1.18B |
| 69 | THC | Tenet Healthcare Corporation | 21.67B | -1.17% | 461,717 | 21.81B |
| 70 | STE | STERIS plc | 21.59B | -1.64% | 1,789,344 | 6.04B |
| 71 | VTRS | Viatris Inc. | 21.19B | -1.07% | 3,889,657 | 14.74B |
| 72 | INSM | Insmed Incorporated | 20.54B | -1.70% | 2,939,874 | 1.14B |
| 73 | MEDP | Medpace Holdings, Inc. | 18.49B | 6.43% | 1,012,082 | 2.78B |
| 74 | ZBH | Zimmer Biomet Holdings, Inc. | 18.09B | -1.19% | 1,449,874 | 8.51B |
| 75 | RVTY | Revvity, Inc. | 17.48B | 0.38% | 1,995,290 | 2.91B |
| 76 | CRL | Charles River Laboratories International, Inc. | 16.46B | 9.33% | 2,453,860 | 4.00B |
| 77 | EXEL | Exelixis, Inc. | 16.00B | 0.30% | 1,494,335 | 2.44B |
| 78 | ASND | Ascendis Pharma A/S | 15.69B | 1.95% | 662,038 | 1.20B |
| 79 | SOLV | Solventum Corporation | 14.75B | 0.32% | 812,791 | 8.31B |
| 80 | NBIX | Neurocrine Biosciences, Inc. | 14.36B | -0.49% | 815,499 | 3.37B |
| 81 | ICLR | ICON Public Limited Company | 14.29B | 6.35% | 1,163,401 | 8.29B |
| 82 | HALO | Halozyme Therapeutics, Inc. | 14.17B | 0.37% | 1,739,667 | 1.66B |
| 83 | JAZZ | Jazz Pharmaceuticals plc | 13.76B | -0.84% | 695,499 | 4.60B |
| 84 | BBIO | BridgeBio Pharma, Inc. | 13.24B | 0.28% | 3,035,888 | 713.07M |
| 85 | BTSG | BrightSpring Health Services, Inc. | 12.99B | -0.10% | 1,641,439 | 14.37B |
| 86 | BAX | Baxter International Inc. | 12.77B | 0.78% | 5,375,651 | 11.47B |
| 87 | PEN | Penumbra, Inc. | 12.74B | -0.24% | 377,604 | 1.50B |
| 88 | SMMT | Summit Therapeutics Inc. | 12.66B | -1.62% | 5,363,464 | - |
| 89 | CORT | Corcept Therapeutics Incorporated | 12.57B | -0.15% | 516,758 | 830.81M |
| 90 | TEM | Tempus AI, Inc. | 12.23B | 1.51% | 3,367,465 | 1.43B |
| 91 | SNN | Smith & Nephew plc | 12.20B | -0.31% | 819,085 | 6.30B |
| 92 | EHC | Encompass Health Corporation | 11.88B | -0.99% | 1,219,542 | 6.21B |
| 93 | AVTR | Avantor, Inc. | 11.67B | 3.85% | 11,633,886 | 6.56B |
| 94 | FMS | Fresenius Medical Care AG | 11.52B | 0.70% | 1,257,236 | 22.19B |
| 95 | TECH | Bio-Techne Corporation | 11.39B | 0.08% | 3,497,679 | 1.22B |
| 96 | DVA | DaVita Inc. | 11.28B | 0.83% | 1,140,264 | 14.01B |
| 97 | ELAN | Elanco Animal Health Incorporated | 11.27B | -0.66% | 4,860,728 | 5.02B |
| 98 | COO | The Cooper Companies, Inc. | 11.21B | -0.25% | 2,153,833 | 4.24B |
| 99 | MOH | Molina Healthcare, Inc. | 11.19B | -2.19% | 1,174,384 | 42.47B |
| 100 | RDY | Dr. Reddy's Laboratories Limited | 10.87B | -0.53% | 2,114,075 | 3.50B |
| 101 | UHS | Universal Health Services, Inc. | 10.78B | -1.48% | 338,446 | 18.11B |
| 102 | ALGN | Align Technology, Inc. | 10.75B | 0.58% | 904,839 | 4.14B |
| 103 | BMRN | BioMarin Pharmaceutical Inc. | 10.69B | -2.18% | 2,506,309 | 3.41B |
| 104 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.58B | -2.05% | 338,288 | 1.28B |
| 105 | GMED | Globus Medical, Inc. | 10.56B | -0.35% | 1,028,935 | 3.14B |
| 106 | GKOS | Glaukos Corporation | 10.43B | 1.97% | 928,450 | 612.84M |
| 107 | QGEN | Qiagen N.V. | 10.34B | 2.25% | 12,100,850 | 2.10B |
| 108 | OSCR | Oscar Health, Inc. | 10.31B | -0.62% | 3,293,997 | 15.32B |
| 109 | RGEN | Repligen Corporation | 10.16B | 0.63% | 903,856 | 785.10M |
| 110 | ENSG | The Ensign Group, Inc. | 10.02B | -1.51% | 284,789 | 5.49B |
| 111 | PCVX | Vaxcyte, Inc. | 9.95B | -4.53% | 3,272,135 | - |
| 112 | TXG | 10x Genomics, Inc. | 9.85B | 5.78% | 3,119,580 | 616.91M |
| 113 | PODD | Insulet Corporation | 9.84B | -0.52% | 1,046,221 | 3.05B |
| 114 | BIO | Bio-Rad Laboratories, Inc. | 9.64B | 1.69% | 360,452 | 2.59B |
| 115 | KRYS | Krystal Biotech, Inc. | 9.54B | -1.00% | 468,235 | 440.48M |
| 116 | HSIC | Henry Schein, Inc. | 9.47B | 0.35% | 1,262,003 | 13.60B |
| 117 | KYMR | Kymera Therapeutics, Inc. | 9.37B | -0.73% | 1,035,389 | 105.00M |
| 118 | TWST | Twist Bioscience Corporation | 9.35B | 4.51% | 2,634,425 | 431.80M |
| 119 | IBRX | ImmunityBio, Inc. | 9.16B | -1.48% | 10,621,259 | 165.79M |
| 120 | CAI | Caris Life Sciences, Inc. | 9.14B | 3.99% | 2,232,102 | 989.61M |
| 121 | HNGE | Hinge Health, Inc. | 9.04B | 4.18% | 1,742,954 | 720.06M |
| 122 | BRKR | Bruker Corporation | 9.01B | 5.68% | 3,523,476 | 3.50B |
| 123 | PTGX | Protagonist Therapeutics, Inc. | 8.93B | 0.07% | 989,917 | 281.99M |
| 124 | CYTK | Cytokinetics, Incorporated | 8.74B | -1.70% | 1,080,526 | 67.67M |
| 125 | SYRE | Spyre Therapeutics, Inc. | 8.69B | 1.70% | 1,153,098 | - |
| 126 | ABVX | ABIVAX Société Anonyme | 8.33B | 0.97% | 947,943 | 5.33M |
| 127 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.31B | -0.14% | 1,371,443 | 669.50M |
| 128 | AXSM | Axsome Therapeutics, Inc. | 8.19B | -2.05% | 524,755 | 776.57M |
| 129 | HQY | HealthEquity, Inc. | 8.10B | 1.33% | 725,093 | 1.36B |
| 130 | ATR | AptarGroup, Inc. | 7.99B | -0.11% | 448,486 | 3.93B |
| 131 | TGTX | TG Therapeutics, Inc. | 7.55B | -2.44% | 1,178,007 | 799.54M |
| 132 | PACS | PACS Group, Inc. | 7.40B | -2.01% | 648,379 | 5.55B |
| 133 | IONS | Ionis Pharmaceuticals, Inc. | 7.36B | -2.49% | 2,266,812 | 874.09M |
| 134 | ALKS | Alkermes plc | 7.29B | -1.43% | 1,808,277 | 1.67B |
| 135 | PRAX | Praxis Precision Medicines, Inc. | 7.16B | -3.03% | 496,950 | 7.46M |
| 136 | AMRX | Amneal Pharmaceuticals, Inc. | 7.04B | 1.81% | 4,660,216 | 3.12B |
| 137 | HIMS | Hims & Hers Health, Inc. | 6.82B | - | 5,975,684 | 2.58B |
| 138 | GRFS | Grifols, S.A. | 6.70B | -0.53% | 310,164 | 8.48B |
| 139 | CHE | Chemed Corporation | 6.66B | -0.91% | 115,688 | 2.60B |
| 140 | IOVA | Iovance Biotherapeutics, Inc. | 6.62B | -1.62% | 10,968,244 | 324.97M |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.54B | -0.15% | 1,412,261 | 1.56B |
| 142 | LGND | Ligand Pharmaceuticals Incorporated | 6.28B | 2.73% | 222,540 | 290.54M |
| 143 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.22B | -4.17% | 836,495 | 840.85M |
| 144 | BLTE | Belite Bio, Inc | 6.19B | -0.51% | 113,766 | - |
| 145 | BLCO | Bausch + Lomb Corporation | 6.14B | 1.48% | 450,782 | 5.32B |
| 146 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.10B | -1.75% | 511,341 | 239.92M |
| 147 | DOCS | Doximity, Inc. | 5.99B | 0.69% | 2,899,415 | 655.57M |
| 148 | GRAL | GRAIL, Inc. | 5.92B | 6.36% | 599,198 | 165.26M |
| 149 | IMVT | Immunovant, Inc. | 5.86B | -0.73% | 1,494,627 | - |
| 150 | MANE | Veradermics, Incorporated | 5.71B | 7.51% | 706,756 | - |
| 151 | WAY | Waystar Holding Corp. | 5.53B | 0.10% | 1,639,142 | 1.21B |
| 152 | TFX | Teleflex Incorporated | 5.53B | -0.57% | 400,446 | 2.25B |
| 153 | CGON | CG Oncology, Inc. | 5.52B | 0.50% | 530,135 | 6.23M |
| 154 | KOD | Kodiak Sciences Inc. | 5.50B | -5.65% | 940,924 | - |
| 155 | MMSI | Merit Medical Systems, Inc. | 5.46B | 0.24% | 521,834 | 1.58B |
| 156 | COGT | Cogent Biosciences, Inc. | 5.46B | 0.61% | 2,216,539 | - |
| 157 | MIRM | Mirum Pharmaceuticals, Inc. | 5.42B | -1.92% | 646,889 | 618.07M |
| 158 | RDNT | RadNet, Inc. | 5.38B | -1.78% | 458,508 | 2.27B |
| 159 | RGC | Regencell Bioscience Holdings Limited | 5.36B | 3.35% | 245,469 | - |
| 160 | HAE | Haemonetics Corporation | 5.33B | -0.93% | 843,470 | 1.35B |
| 161 | ORKA | Oruka Therapeutics, Inc. | 5.29B | 1.05% | 953,372 | - |
| 162 | SRRK | Scholar Rock Holding Corporation | 5.24B | 3.97% | 4,600,574 | - |
| 163 | PTCT | PTC Therapeutics, Inc. | 5.23B | -0.48% | 944,162 | 1.01B |
| 164 | STVN | Stevanato Group S.p.A. | 5.14B | -1.00% | 355,758 | 1.40B |
| 165 | SHC | Sotera Health Company | 5.07B | -0.89% | 2,716,459 | 1.22B |
| 166 | ERAS | Erasca, Inc. | 5.07B | -0.89% | 3,844,612 | - |
| 167 | MMED | MiniMed Group, Inc. | 5.01B | 1.77% | 10,345,111 | 3.22B |
| 168 | CON | Concentra Group Holdings Parent, Inc. | 4.98B | 0.85% | 1,242,355 | 2.29B |
| 169 | TVTX | Travere Therapeutics, Inc. | 4.96B | 0.54% | 2,164,172 | 591.33M |
| 170 | BLLN | BillionToOne, Inc. | 4.94B | 1.13% | 358,305 | 397.41M |
| 171 | CRSP | CRISPR Therapeutics AG | 4.88B | 1.24% | 1,169,345 | 13.39M |
| 172 | HTFL | HeartFlow, Inc. | 4.85B | 0.41% | 1,574,915 | 212.07M |
| 173 | DFTX | Definium Therapeutics, Inc. | 4.77B | 1.14% | 2,906,132 | - |
| 174 | LFST | LifeStance Health Group, Inc. | 4.71B | 0.90% | 3,554,079 | 1.58B |
| 175 | OPCH | Option Care Health, Inc. | 4.69B | -0.22% | 2,224,122 | 5.69B |
| 176 | TNGX | Tango Therapeutics, Inc. | 4.55B | 6.85% | 5,557,300 | 53.81M |
| 177 | DNTH | Dianthus Therapeutics, Inc. | 4.37B | -0.83% | 1,194,113 | 1.90M |
| 178 | LIVN | LivaNova PLC | 4.32B | -1.59% | 556,097 | 1.47B |
| 179 | ITGR | Integer Holdings Corporation | 4.31B | - | 764,081 | 1.84B |
| 180 | EWTX | Edgewise Therapeutics, Inc. | 4.31B | -0.25% | 1,828,337 | - |
| 181 | INDV | Indivior Pharmaceuticals, Inc. | 4.11B | 0.06% | 3,343,615 | 1.33B |
| 182 | ADPT | Adaptive Biotechnologies Corporation | 4.04B | 3.73% | 1,743,972 | 308.08M |
| 183 | RLAY | Relay Therapeutics, Inc. | 4.03B | -0.22% | 1,598,187 | 10.35M |
| 184 | ICUI | ICU Medical, Inc. | 4.02B | -0.25% | 219,974 | 2.16B |
| 185 | ARQT | Arcutis Biotherapeutics, Inc. | 4.01B | -2.89% | 1,687,442 | 463.98M |
| 186 | ABCL | AbCellera Biologics Inc. | 3.97B | 4.53% | 1,614,470 | 66.17M |
| 187 | IRTC | iRhythm Holdings, Inc. | 3.74B | -0.26% | 422,846 | 825.34M |
| 188 | NVST | Envista Holdings Corporation | 3.72B | 0.96% | 5,304,312 | 2.86B |
| 189 | VCYT | Veracyte, Inc. | 3.72B | 3.19% | 812,036 | 561.90M |
| 190 | NHC | National HealthCare Corporation | 3.69B | -4.98% | 116,465 | 1.56B |
| 191 | CDNA | CareDx, Inc. | 3.66B | 2.23% | 1,635,583 | 458.09M |
| 192 | PLSE | Pulse Biosciences, Inc. | 3.66B | 0.92% | 315,591 | 1.19M |
| 193 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.64B | 0.90% | 1,247,960 | -665.00K |
| 194 | OGN | Organon & Co. | 3.61B | -0.07% | 2,555,621 | 6.13B |
| 195 | LEGN | Legend Biotech Corporation | 3.61B | -2.00% | 1,559,437 | 1.27B |
| 196 | XENE | Xenon Pharmaceuticals Inc. | 3.48B | -0.88% | 1,079,389 | 7.50M |
| 197 | ACAD | Acadia Pharmaceuticals Inc. | 3.48B | -1.22% | 1,409,867 | 1.14B |
| 198 | LQDA | Liquidia Corporation | 3.48B | 6.91% | 3,878,514 | 450.91M |
| 199 | PBLS | Parabilis Medicines, Inc. | 3.44B | 2.84% | 1,391,966 | 148.00K |
| 200 | IDYA | IDEAYA Biosciences, Inc. | 3.42B | 0.31% | 648,772 | 234.13M |
| 201 | WRBY | Warby Parker Inc. | 3.17B | 0.04% | 1,746,094 | 911.61M |
| 202 | TLX | Telix Pharmaceuticals Limited | 3.12B | -10.13% | 874,375 | 890.79M |
| 203 | TARS | Tarsus Pharmaceuticals, Inc. | 3.09B | -0.75% | 945,908 | 606.33M |
| 204 | VKTX | Viking Therapeutics, Inc. | 3.08B | -1.24% | 2,898,333 | - |
| 205 | ELVN | Enliven Therapeutics, Inc. | 3.06B | 1.38% | 2,052,398 | - |
| 206 | CELC | Celcuity Inc. | 3.01B | 2.60% | 1,590,616 | - |
| 207 | DYN | Dyne Therapeutics, Inc. | 3.00B | -1.23% | 1,789,806 | - |
| 208 | DNLI | Denali Therapeutics Inc. | 2.99B | -1.32% | 1,429,201 | 3.60M |
| 209 | ATRC | AtriCure, Inc. | 2.93B | - | 566,267 | 569.62M |
| 210 | ACHC | Acadia Healthcare Company, Inc. | 2.93B | - | 1,124,833 | 3.37B |
| 211 | IRON | Disc Medicine, Inc. | 2.92B | -4.38% | 4,600,974 | - |
| 212 | PRVA | Privia Health Group, Inc. | 2.87B | -2.01% | 1,021,810 | 2.36B |
| 213 | NRIX | Nurix Therapeutics, Inc. | 2.84B | -0.31% | 2,928,298 | 701.94M |
| 214 | AVAH | Aveanna Healthcare Holdings Inc. | 2.83B | 1.88% | 2,779,580 | 2.60B |
| 215 | ZLAB | Zai Lab Limited | 2.72B | -3.51% | 1,197,863 | 449.61M |
| 216 | VRDN | Viridian Therapeutics, Inc. | 2.61B | 2.59% | 1,920,863 | 71.13M |
| 217 | MBX | MBX Biosciences, Inc. | 2.60B | 0.78% | 400,359 | - |
| 218 | NEOG | Neogen Corporation | 2.57B | 0.60% | 2,118,740 | 884.00M |
| 219 | NAMS | NewAmsterdam Pharma Company N.V. | 2.57B | -0.05% | 1,252,576 | 7.12M |
| 220 | CLOV | Clover Health Investments, Corp. | 2.54B | -0.42% | 2,872,031 | 2.48B |
| 221 | TMDX | TransMedics Group, Inc. | 2.51B | -3.14% | 685,185 | 668.47M |
| 222 | BEAM | Beam Therapeutics Inc. | 2.48B | -0.36% | 1,167,219 | 156.04M |
| 223 | HCM | HUTCHMED (China) Limited | 2.48B | -2.51% | 72,317 | 549.12M |
| 224 | GRDN | Guardian Pharmacy Services, Inc. | 2.47B | -6.90% | 429,330 | 1.46B |
| 225 | ADMA | ADMA Biologics, Inc. | 2.47B | -1.96% | 2,005,751 | 512.28M |
| 226 | SLS | SELLAS Life Sciences Group, Inc. | 2.45B | 1.34% | 5,644,827 | - |
| 227 | RCUS | Arcus Biosciences, Inc. | 2.43B | -19.58% | 3,971,981 | 117.00M |
| 228 | BHC | Bausch Health Companies Inc. | 2.41B | 0.47% | 759,098 | 10.85B |
| 229 | BKD | Brookdale Senior Living Inc. | 2.41B | 0.10% | 4,112,634 | 2.93B |
| 230 | SUPN | Supernus Pharmaceuticals, Inc. | 2.40B | -0.02% | 1,005,963 | 830.44M |
| 231 | PGEN | Precigen, Inc. | 2.36B | -3.37% | 5,632,453 | 85.72M |
| 232 | CLDX | Celldex Therapeutics, Inc. | 2.31B | -3.04% | 1,117,511 | 158.00K |
| 233 | FTRE | Fortrea Holdings Inc. | 2.29B | 5.62% | 2,473,274 | 2.68B |
| 234 | PBH | Prestige Consumer Healthcare Inc. | 2.27B | -2.92% | 424,282 | 1.10B |
| 235 | AUPH | Aurinia Pharmaceuticals Inc. | 2.25B | 0.96% | 637,912 | 311.51M |
| 236 | VERA | Vera Therapeutics, Inc. | 2.25B | 3.79% | 2,083,558 | - |
| 237 | UFPT | UFP Technologies, Inc. | 2.25B | -0.42% | 94,340 | 631.64M |
| 238 | HRMY | Harmony Biosciences Holdings, Inc. | 2.23B | -1.01% | 1,062,423 | 959.90M |
| 239 | MD | Pediatrix Medical Group, Inc. | 2.23B | 0.07% | 457,632 | 1.95B |
| 240 | AGIO | Agios Pharmaceuticals, Inc. | 2.22B | 1.47% | 849,792 | 98.34M |
| 241 | PRGO | Perrigo Company plc | 2.21B | -1.61% | 2,359,205 | 4.14B |
| 242 | NEO | NeoGenomics, Inc. | 2.19B | 2.53% | 1,493,568 | 766.30M |
| 243 | ALMR | Alamar Biosciences, Inc. | 2.18B | 11.68% | 1,141,204 | 100.42M |
| 244 | PGNY | Progyny, Inc. | 2.18B | -0.49% | 712,708 | 1.31B |
| 245 | RXRX | Recursion Pharmaceuticals, Inc. | 2.18B | -0.55% | 18,399,678 | 54.86M |
| 246 | ADUS | Addus HomeCare Corporation | 2.16B | -0.11% | 163,545 | 1.48B |
| 247 | PHVS | Pharvaris N.V. | 2.15B | -0.78% | 393,547 | - |
| 248 | AXGN | Axogen, Inc. | 2.14B | 0.86% | 1,131,514 | 251.17M |
| 249 | TRLV | Trulieve Cannabis Corp. | 2.12B | 1.95% | 1,418,426 | 1.14B |
| 250 | VCEL | Vericel Corporation | 2.10B | 0.89% | 431,996 | 306.30M |
| 251 | WGS | GeneDx Holdings Corp. | 2.06B | 0.29% | 832,725 | 454.43M |
| 252 | INSP | Inspire Medical Systems, Inc. | 2.05B | -0.38% | 554,251 | 898.74M |
| 253 | IMNM | Immunome, Inc. | 2.04B | 0.45% | 1,543,903 | 4.02M |
| 254 | SGRY | Surgery Partners, Inc. | 2.00B | -0.58% | 2,355,396 | 3.37B |
| 255 | ZYME | Zymeworks Inc. | 2.00B | 4.48% | 1,318,833 | 37.13M |
| 256 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.98B | -2.39% | 5,033,549 | 940.61M |
| 257 | XERS | Xeris Biopharma Holdings, Inc. | 1.97B | -3.10% | 1,676,960 | 335.41M |
| 258 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.97B | 5.14% | 1,699,822 | 208.78M |
| 259 | SRPT | Sarepta Therapeutics, Inc. | 1.96B | -3.18% | 2,033,900 | 1.97B |
| 260 | LKFT | Lakefront Biotherapeutics NV | 1.94B | -0.55% | 133,987 | 1.13B |
| 261 | ADRX | ADARx Pharmaceuticals, Inc. | 1.92B | -3.11% | 441,510 | 6.13M |
| 262 | LMAT | LeMaitre Vascular, Inc. | 1.91B | 0.32% | 216,660 | 262.43M |
| 263 | ASTH | Astrana Health, Inc. | 1.91B | -3.19% | 222,909 | 3.84B |
| 264 | SEPN | Septerna, Inc. | 1.90B | 3.58% | 286,393 | 98.88M |
| 265 | BFLY | Butterfly Network, Inc. | 1.89B | -2.87% | 4,948,997 | 112.14M |
| 266 | XNCR | Xencor, Inc. | 1.87B | 0.88% | 1,479,576 | 104.97M |
| 267 | MLYS | Mineralys Therapeutics, Inc. | 1.87B | -2.22% | 643,573 | - |
| 268 | ESTA | Establishment Labs Holdings Inc. | 1.86B | 1.98% | 474,801 | 245.82M |
| 269 | ALVO | Alvotech | 1.83B | 0.20% | 480,479 | 494.61M |
| 270 | ZBIO | Zenas BioPharma, Inc. | 1.83B | -0.35% | 483,888 | 1.00M |
| 271 | PVLA | Palvella Therapeutics, Inc. | 1.82B | 2.15% | 245,650 | - |
| 272 | TRVI | Trevi Therapeutics, Inc. | 1.82B | -0.47% | 2,650,536 | - |
| 273 | NVAX | Novavax, Inc. | 1.82B | -3.67% | 5,002,665 | 413.80M |
| 274 | NVCR | NovoCure Limited | 1.82B | -0.76% | 2,599,222 | 699.19M |
| 275 | XRAY | DENTSPLY SIRONA Inc. | 1.81B | 2.37% | 4,643,445 | 3.64B |
| 276 | MAZE | Maze Therapeutics, Inc. | 1.81B | 0.40% | 1,068,269 | 20.00M |
| 277 | VIR | Vir Biotechnology, Inc. | 1.79B | -1.58% | 1,136,654 | 303.23M |
| 278 | SDGR | Schrödinger, Inc. | 1.79B | 2.14% | 1,063,010 | 259.04M |
| 279 | BHVN | Biohaven Ltd. | 1.77B | -0.51% | 1,443,646 | - |
| 280 | ALHC | Alignment Healthcare, Inc. | 1.75B | -0.82% | 2,759,276 | 4.58B |
| 281 | URGN | UroGen Pharma Ltd. | 1.73B | 1.34% | 776,971 | 188.73M |
| 282 | ABSI | Absci Corporation | 1.72B | 10.69% | 5,348,439 | 1.56M |
| 283 | BRVE | Braveheart Bio, Inc. | 1.72B | 3.80% | 224,144 | - |
| 284 | NUVB | Nuvation Bio Inc. | 1.70B | 1.68% | 4,501,229 | 169.90M |
| 285 | ARDT | Ardent Health, Inc. | 1.70B | -0.50% | 314,062 | 6.41B |
| 286 | PSNL | Personalis, Inc. | 1.70B | -0.25% | 2,791,316 | 69.67M |
| 287 | MESO | Mesoblast Limited | 1.70B | 3.38% | 555,337 | 120.25M |
| 288 | GENB | Generate Biomedicines, Inc. | 1.68B | 1.63% | 155,407 | 26.48M |
| 289 | ATEC | Alphatec Holdings, Inc. | 1.68B | - | 1,694,343 | 815.05M |
| 290 | KLRA | Kailera Therapeutics, Inc. | 1.67B | 0.23% | 1,282,098 | - |
| 291 | AMN | AMN Healthcare Services, Inc. | 1.67B | 3.34% | 1,214,489 | 3.43B |
| 292 | OMCL | Omnicell, Inc. | 1.66B | -0.41% | 459,088 | 1.25B |
| 293 | STOK | Stoke Therapeutics, Inc. | 1.66B | -3.49% | 2,257,813 | 27.59M |
| 294 | IMCR | Immunocore Holdings plc | 1.65B | -1.56% | 1,159,320 | 430.78M |
| 295 | COAG | Hemab Therapeutics Holdings, Inc. | 1.65B | 3.42% | 388,257 | - |
| 296 | CMPS | COMPASS Pathways plc | 1.64B | -0.50% | 1,826,510 | - |
| 297 | NTLA | Intellia Therapeutics, Inc. | 1.63B | -1.60% | 2,442,928 | 59.51M |
| 298 | KMTS | Kestra Medical Technologies, Ltd. | 1.63B | -3.43% | 685,482 | 106.73M |
| 299 | AZTA | Azenta, Inc. | 1.61B | 2.88% | 635,152 | 613.81M |
| 300 | PAHC | Phibro Animal Health Corporation | 1.60B | 1.29% | 169,198 | 1.52B |
| 301 | SNDA | Sonida Senior Living, Inc. | 1.59B | -2.62% | 423,991 | 481.07M |
| 302 | QURE | uniQure N.V. | 1.57B | -0.11% | 1,115,300 | 18.67M |
| 303 | GPCR | Structure Therapeutics Inc. | 1.57B | -3.80% | 803,895 | - |
| 304 | RARE | Ultragenyx Pharmaceutical Inc. | 1.56B | -0.62% | 2,824,764 | 717.00M |
| 305 | CERT | Certara, Inc. | 1.55B | 4.04% | 1,717,465 | 421.75M |
| 306 | ANIP | ANI Pharmaceuticals, Inc. | 1.55B | -0.59% | 344,975 | 978.38M |
| 307 | TRAX | First Tracks Biotherapeutics, Inc. | 1.53B | 3.68% | 711,538 | - |
| 308 | AGL | agilon health, inc. | 1.53B | -0.80% | 208,681 | 5.92B |
| 309 | INVA | Innoviva, Inc. | 1.51B | -1.74% | 441,297 | 440.00M |
| 310 | FRNM | Freenome, Inc. | 1.51B | -0.36% | 375,323 | 35.41M |
| 311 | AAPG | Ascentage Pharma Group International | 1.50B | 2.64% | 1,485 | 94.61M |
| 312 | HCSG | Healthcare Services Group, Inc. | 1.49B | 0.98% | 1,586,202 | 1.86B |
| 313 | KRSA | Korsana Biosciences, Inc. | 1.48B | 4.87% | 129,773 | - |
| 314 | NBTX | Nanobiotix S.A. | 1.47B | 7.00% | 165,343 | 13.15M |
| 315 | PCRX | Pacira BioSciences, Inc. | 1.45B | -0.14% | 1,488,259 | 746.16M |
| 316 | INBX | Inhibrx Biosciences, Inc. | 1.45B | 3.21% | 239,005 | 1.30M |
| 317 | ORIC | ORIC Pharmaceuticals, Inc. | 1.44B | 0.51% | 1,568,502 | - |
| 318 | PNTG | The Pennant Group, Inc. | 1.43B | -1.06% | 207,525 | 1.10B |
| 319 | ANAB | AnaptysBio, Inc. | 1.43B | 5.52% | 664,422 | 106.09M |
| 320 | OCUL | Ocular Therapeutix, Inc. | 1.42B | -2.56% | 2,489,569 | 52.06M |
| 321 | TYRA | Tyra Biosciences, Inc. | 1.42B | 0.64% | 724,289 | - |
| 322 | CNMD | CONMED Corporation | 1.41B | -0.99% | 442,962 | 1.37B |
| 323 | ETON | Eton Pharmaceuticals, Inc. | 1.41B | -1.77% | 318,934 | 105.60M |
| 324 | NUTX | Nutex Health Inc. | 1.35B | -0.69% | 73,579 | 846.72M |
| 325 | TSHA | Taysha Gene Therapies, Inc. | 1.34B | 0.24% | 3,511,182 | 5.49M |
| 326 | DMRA | Damora Therapeutics, Inc. | 1.33B | 4.16% | 682,732 | - |
| 327 | NKTR | Nektar Therapeutics | 1.31B | -2.42% | 619,302 | 54.59M |
| 328 | GHRS | GH Research PLC | 1.30B | -1.33% | 393,649 | - |
| 329 | USPH | U.S. Physical Therapy, Inc. | 1.29B | -0.85% | 111,429 | 804.27M |
| 330 | LBRX | LB Pharmaceuticals Inc | 1.27B | -4.32% | 246,884 | - |
| 331 | CRON | Cronos Group Inc. | 1.25B | 3.35% | 1,143,979 | 179.09M |
| 332 | INNV | InnovAge Holding Corp. | 1.25B | -0.11% | 545,133 | 989.71M |
| 333 | DRTS | Alpha Tau Medical Ltd. | 1.24B | 2.98% | 499,057 | - |
| 334 | GDRX | GoodRx Holdings, Inc. | 1.22B | 1.42% | 1,763,917 | 785.23M |
| 335 | OMDA | Omada Health, Inc. | 1.20B | 1.65% | 1,298,582 | 309.76M |
| 336 | RAPP | Rapport Therapeutics, Inc. | 1.20B | -14.67% | 2,157,644 | 20.00M |
| 337 | KARD | Kardigan, Inc. | 1.20B | -4.89% | 477,835 | - |
| 338 | ENOV | Enovis Corporation | 1.20B | 0.58% | 1,190,982 | 2.30B |
| 339 | BVS | Bioventus Inc. | 1.20B | 2.08% | 421,506 | 581.85M |
| 340 | OPK | OPKO Health, Inc. | 1.19B | -3.61% | 2,483,305 | 587.90M |
| 341 | SVRA | Savara Inc. | 1.19B | -1.89% | 2,086,103 | - |
| 342 | BCAX | Bicara Therapeutics Inc. | 1.19B | -2.40% | 656,718 | - |
| 343 | SLN | Silence Therapeutics plc | 1.18B | 0.31% | 2,801,252 | 615.00K |
| 344 | OMER | Omeros Corporation | 1.18B | -1.75% | 698,094 | 38.42M |
| 345 | SNDX | Syndax Pharmaceuticals, Inc. | 1.17B | -0.75% | 2,587,581 | 252.25M |
| 346 | TDOC | Teladoc Health, Inc. | 1.14B | 1.45% | 2,250,144 | 2.49B |
| 347 | TNDM | Tandem Diabetes Care, Inc. | 1.14B | -1.09% | 1,532,412 | 1.04B |
| 348 | IRMD | IRADIMED CORPORATION | 1.12B | -0.49% | 65,696 | 86.34M |
| 349 | VOR | Vor Biopharma Inc. | 1.12B | -0.47% | 817,349 | - |
| 350 | VSTM | Verastem, Inc. | 1.12B | -1.39% | 2,792,345 | 87.53M |
| 351 | AORT | Artivion, Inc. | 1.12B | -0.82% | 473,805 | 471.47M |
| 352 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.11B | 1.00% | 390,199 | 730.02M |
| 353 | AVLN | Avalyn Pharma Inc. | 1.11B | 1.95% | 209,633 | - |
| 354 | REPL | Replimune Group, Inc. | 1.10B | 2.63% | 2,202,144 | - |
| 355 | AHG | Akso Health Group | 1.09B | 3.53% | 4,500 | 13.83M |
| 356 | STAA | STAAR Surgical Company | 1.08B | -3.18% | 338,439 | 339.59M |
| 357 | LTGO | Latigo Biotherapeutics, Inc. | 1.08B | 7.15% | 173,758 | - |
| 358 | HROW | Harrow, Inc. | 1.06B | 0.61% | 523,853 | 275.59M |
| 359 | SPTX | Seaport Therapeutics, Inc. | 1.06B | 2.33% | 134,581 | - |
| 360 | IMTX | Immatics N.V. | 1.05B | 2.40% | 1,978,688 | 47.65M |
| 361 | CSTL | Castle Biosciences, Inc. | 1.05B | 3.68% | 336,585 | 357.28M |
| 362 | PRCT | PROCEPT BioRobotics Corporation | 1.05B | -2.92% | 733,160 | 337.34M |
| 363 | CBLL | CeriBell, Inc. | 1.04B | -1.95% | 472,005 | 101.96M |
| 364 | LMRI | Lumexa Imaging Holdings, Inc. | 1.04B | 1.22% | 315,226 | 1.04B |
| 365 | JANX | Janux Therapeutics, Inc. | 1.04B | -1.57% | 587,297 | 24.00M |
| 366 | HSTM | HealthStream, Inc. | 1.03B | -0.77% | 204,588 | 321.12M |
| 367 | CTY | City Therapeutics, Inc. | 1.02B | -1.92% | 283,071 | 14.34M |
| 368 | MNKD | MannKind Corporation | 980.70M | -1.61% | 2,421,339 | 393.63M |
| 369 | BBNX | Beta Bionics, Inc. | 967.03M | 3.55% | 1,440,594 | 119.01M |
| 370 | QDEL | QuidelOrtho Corporation | 966.23M | -0.84% | 3,317,388 | 2.67B |
| 371 | JBIO | Jade Biosciences, Inc. | 962.23M | 1.82% | 931,928 | - |
| 372 | CGEM | Cullinan Therapeutics, Inc. | 958.24M | 0.40% | 690,975 | - |
| 373 | GLUE | Monte Rosa Therapeutics, Inc. | 957.22M | -1.23% | 1,077,909 | 28.73M |
| 374 | MGTX | MeiraGTx Holdings plc | 945.06M | -1.30% | 635,553 | 397.50M |
| 375 | AVBP | ArriVent BioPharma, Inc. | 942.76M | 1.43% | 1,489,198 | - |
| 376 | SIBN | SI-BONE, Inc. | 933.12M | 1.36% | 812,750 | 213.60M |
| 377 | SGP | SpyGlass Pharma, Inc. | 926.84M | 5.93% | 86,088 | - |
| 378 | IART | Integra LifeSciences Holdings Corporation | 920.83M | -11.18% | 2,013,853 | 1.66B |
| 379 | ANRO | Alto Neuroscience, Inc. | 915.13M | -4.47% | 663,456 | - |
| 380 | RIGL | Rigel Pharmaceuticals, Inc. | 913.07M | 1.60% | 195,890 | 276.79M |
| 381 | AKTS | Aktis Oncology, Inc. | 912.16M | 1.99% | 390,679 | 10.06M |
| 382 | ODTX | Odyssey Therapeutics, Inc. | 910.45M | 0.05% | 255,338 | 99.00K |
| 383 | MLTX | MoonLake Immunotherapeutics | 906.39M | 3.20% | 1,163,559 | - |
| 384 | IVA | Inventiva S.A. | 899.43M | 8.90% | 5,240,841 | 2.81M |
| 385 | ALMS | Alumis Inc. | 881.45M | 1.64% | 1,230,135 | 7.40M |
| 386 | KURA | Kura Oncology, Inc. | 878.93M | -1.00% | 1,150,976 | 77.23M |
| 387 | OBX | Obsidian Therapeutics, Inc. | 860.50M | 5.13% | 332,844 | - |
| 388 | CRVS | Corvus Pharmaceuticals, Inc. | 845.42M | -1.76% | 868,477 | - |
| 389 | ABUS | Arbutus Biopharma Corporation | 827.00M | -3.46% | 3,025,276 | 181.72M |
| 390 | SLBT | SL Science Holding Limited | 826.89M | -3.33% | 107,387 | 3.27M |
| 391 | AHCO | AdaptHealth Corp. | 813.80M | - | 1,345,029 | 3.36B |
| 392 | GMRS | GMR Solutions Inc. | 808.31M | -0.76% | 576,343 | 5.88B |
| 393 | INMD | InMode Ltd. | 806.46M | -0.78% | 423,855 | 374.63M |
| 394 | HELP | Helus Pharma Inc. | 787.59M | -1.46% | 932,635 | - |
| 395 | APMD | Apnimed, Inc. | 786.82M | 2.11% | 295,399 | 115.12M |
| 396 | ARDX | Ardelyx, Inc. | 779.96M | -2.49% | 3,016,844 | 450.89M |
| 397 | VREX | Varex Imaging Corporation | 776.36M | 0.11% | 465,211 | 865.00M |
| 398 | PHR | Phreesia, Inc. | 760.99M | 1.74% | 1,023,131 | 507.79M |
| 399 | IAM | Iambic Therapeutics, Inc. | 748.93M | -1.31% | 473,505 | 18.25M |
| 400 | COLL | Collegium Pharmaceutical, Inc. | 746.01M | -1.36% | 480,416 | 808.21M |
| 401 | GERN | Geron Corporation | 745.27M | -6.45% | 8,692,627 | 204.56M |
| 402 | ANNX | Annexon, Inc. | 731.78M | 0.78% | 4,948,088 | - |
| 403 | ANL | Adlai Nortye Group Ltd. | 725.12M | 5.83% | 532,596 | 18.06M |
| 404 | CTKB | Cytek Biosciences, Inc. | 714.91M | 3.00% | 1,093,127 | 206.71M |
| 405 | OABI | OmniAb, Inc. | 714.59M | -0.91% | 3,176,453 | 38.46M |
| 406 | SGMT | Sagimet Biosciences Inc. | 708.38M | 2.57% | 1,578,098 | - |
| 407 | IMMX | Immix Biopharma, Inc. | 705.50M | -4.49% | 1,536,942 | - |
| 408 | SANA | Sana Biotechnology, Inc. | 703.50M | -0.42% | 2,398,423 | - |
| 409 | FDMT | 4D Molecular Therapeutics, Inc. | 697.18M | -3.66% | 2,019,204 | 92.01M |
| 410 | STLN | Starling Oncology, Inc. | 696.09M | 3.02% | 1,454,008 | 587.24M |
| 411 | LXRX | Lexicon Pharmaceuticals, Inc. | 694.13M | -1.27% | 1,395,518 | 41.47M |
| 412 | SLDB | Solid Biosciences Inc. | 687.31M | 0.16% | 1,147,183 | - |
| 413 | PRME | Prime Medicine, Inc. | 677.82M | -2.81% | 2,436,294 | 4.07M |
| 414 | NVCT | Nuvectis Pharma, Inc. | 675.42M | 0.68% | 203,570 | - |
| 415 | DNA | Ginkgo Bioworks Holdings, Inc. | 674.08M | 1.52% | 1,623,409 | 132.42M |
| 416 | DSGN | Design Therapeutics, Inc. | 671.50M | -3.33% | 328,963 | - |
| 417 | AURA | Aura Biosciences, Inc. | 669.93M | -1.52% | 933,552 | - |
| 418 | ACHV | Achieve Life Sciences, Inc. | 669.90M | - | 2,467,778 | - |
| 419 | PACB | Pacific Biosciences of California, Inc. | 665.18M | 9.18% | 13,492,138 | 159.27M |
| 420 | WVE | Wave Life Sciences, Inc. | 664.05M | -1.46% | 2,172,850 | 65.37M |
| 421 | PHAR | Pharming Group N.V. | 658.29M | -1.03% | 10,920 | 366.48M |
| 422 | AVTX | Avalo Therapeutics, Inc. | 657.50M | -0.81% | 930,108 | 59.00K |
| 423 | ATTO | Attovia Therapeutics, Inc. | 647.33M | 1.00% | 279,887 | 1.80M |
| 424 | CADL | Candel Therapeutics, Inc. | 640.46M | -3.13% | 1,084,939 | - |
| 425 | SOPH | SOPHiA GENETICS SA | 625.69M | 6.06% | 591,854 | 86.17M |
| 426 | GYRE | Gyre Therapeutics, Inc. | 625.60M | -4.38% | 131,239 | 109.82M |
| 427 | CLYM | Climb Bio, Inc. | 624.33M | 0.65% | 930,384 | - |
| 428 | KIDS | OrthoPediatrics Corp. | 622.46M | 1.45% | 490,438 | 252.72M |
| 429 | OLMA | Olema Pharmaceuticals, Inc. | 616.86M | -2.76% | 1,236,202 | - |
| 430 | ZVRA | Zevra Therapeutics, Inc. | 615.22M | -1.05% | 500,580 | 136.07M |
| 431 | CRMD | CorMedix Inc. | 607.19M | 2.91% | 1,048,711 | 462.25M |
| 432 | EVO | Evotec SE | 600.91M | 5.41% | 52,986 | 819.47M |
| 433 | WEAV | Weave Communications, Inc. | 591.19M | - | 3,765,240 | 257.79M |
| 434 | DBVT | DBV Technologies S.A. | 587.70M | 1.48% | 1,409,867 | 5.04M |
| 435 | IRWD | Ironwood Pharmaceuticals, Inc. | 586.60M | -2.20% | 1,503,012 | 389.32M |
| 436 | AVR | Anteris Technologies Global Corp. | 585.94M | -4.45% | 1,391,731 | 2.24M |
| 437 | ETRA | Electra Therapeutics, Inc. | 568.04M | 2.72% | 126,063 | - |
| 438 | CBIO | Crescent Biopharma, Inc. | 563.69M | 0.77% | 250,361 | 11.88M |
| 439 | PBYI | Puma Biotechnology, Inc. | 562.66M | 1.30% | 306,256 | 231.24M |
| 440 | ACRS | Aclaris Therapeutics, Inc. | 560.83M | 1.06% | 2,375,811 | 8.22M |
| 441 | STTK | Shattuck Labs, Inc. | 560.03M | -4.45% | 1,197,998 | 1.00M |
| 442 | PHAT | Phathom Pharmaceuticals, Inc. | 558.39M | -3.83% | 784,163 | 239.66M |
| 443 | FLGT | Fulgent Genetics, Inc. | 553.88M | -0.98% | 193,389 | 323.93M |
| 444 | EVH | Evolent Health, Inc. | 546.08M | -0.82% | 1,467,730 | 2.10B |
| 445 | MDXG | MiMedx Group, Inc. | 545.14M | -11.58% | 2,602,446 | 355.17M |
| 446 | MYGN | Myriad Genetics, Inc. | 532.77M | 0.54% | 4,947,006 | 806.60M |
| 447 | FTH | Faeth Therapeutics, Inc. | 531.54M | -1.06% | 182,411 | - |
| 448 | ENTX | Entera Bio Ltd. | 530.46M | 0.99% | 784,597 | 42.00K |
| 449 | TCMD | Tactile Systems Technology, Inc. | 527.35M | -1.02% | 148,915 | 350.31M |
| 450 | CTMX | CytomX Therapeutics, Inc. | 522.96M | -4.38% | 3,110,980 | 18.30M |
| 451 | NGNE | Neurogene Inc. | 521.90M | 2.68% | 588,803 | 925.00K |
| 452 | VALN | Valneva SE | 514.08M | -2.28% | 7,259 | 163.30M |
| 453 | EPRX | Eupraxia Pharmaceuticals Inc. | 512.18M | 1.84% | 348,313 | - |
| 454 | AQST | Aquestive Therapeutics, Inc. | 512.09M | 0.74% | 1,438,746 | 54.09M |
| 455 | DCTH | Delcath Systems, Inc. | 510.07M | -0.41% | 277,760 | 95.42M |
| 456 | DRUG | Bright Minds Biosciences Inc. | 508.45M | -8.62% | 156,349 | - |
| 457 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 458 | ANGO | AngioDynamics, Inc. | 500.03M | 0.68% | 725,278 | 325.38M |
| 459 | ARVN | Arvinas, Inc. | 493.99M | -1.37% | 653,389 | 316.70M |
| 460 | BLSM | BlossomHill Therapeutics, Inc. | 492.98M | 7.71% | 76,218 | - |
| 461 | EOLS | Evolus, Inc. | 488.77M | 0.41% | 912,516 | 316.49M |
| 462 | MASS | 908 Devices Inc. | 487.74M | 2.52% | 570,300 | 60.84M |
| 463 | OCS | Oculis Holding AG | 487.68M | 5.47% | 324,100 | 1.45M |
| 464 | MNPR | Monopar Therapeutics Inc. | 485.63M | -2.53% | 76,596 | - |
| 465 | SSII | SS Innovations International, Inc. | 482.93M | -5.12% | 25,530 | 52.40M |
| 466 | OVID | Ovid Therapeutics Inc. | 482.39M | 4.66% | 5,003,039 | 1.58M |
| 467 | CERS | Cerus Corporation | 481.64M | 3.46% | 1,872,805 | 221.55M |
| 468 | SGHT | Sight Sciences, Inc. | 479.27M | 0.93% | 154,709 | 83.38M |
| 469 | BWAY | BrainsWay Ltd. | 477.05M | -0.42% | 41,201 | 60.70M |
| 470 | RGNX | REGENXBIO Inc. | 473.31M | -3.11% | 945,329 | 174.48M |
| 471 | RCEL | AVITA Medical, Inc. | 472.87M | 10.80% | 844,260 | 75.63M |
| 472 | DMAC | DiaMedica Therapeutics Inc. | 468.61M | 0.23% | 155,376 | - |
| 473 | ALLO | Allogene Therapeutics, Inc. | 459.50M | - | 4,728,814 | 4.64M |
| 474 | MPLT | MapLight Therapeutics, Inc. | 453.50M | -0.97% | 343,844 | - |
| 475 | NRC | NRC Health | 449.25M | -1.84% | 48,309 | 140.00M |
| 476 | KMDA | Kamada Ltd. | 448.96M | -0.89% | 51,085 | 191.85M |
| 477 | AGMB | AgomAb Therapeutics NV | 448.65M | 4.35% | 43,231 | - |
| 478 | NPCE | NeuroPace, Inc. | 447.93M | -3.40% | 64,247 | 106.99M |
| 479 | PROK | ProKidney Corp. | 435.34M | - | 601,286 | 818.00K |
| 480 | ALT | Altimmune, Inc. | 433.77M | -3.04% | 4,152,402 | 31.00K |
| 481 | EIKN | Eikon Therapeutics, Inc. | 433.32M | -2.20% | 240,637 | - |
| 482 | AUTL | Autolus Therapeutics plc | 431.18M | -2.41% | 1,825,370 | 117.39M |
| 483 | TLRY | Tilray Brands, Inc. | 428.25M | -3.63% | 4,035,627 | 963.10M |
| 484 | TECX | Tectonic Therapeutic, Inc. | 427.15M | 0.11% | 152,825 | - |
| 485 | SENS | Senseonics Holdings, Inc. | 421.41M | -2.92% | 530,356 | 48.55M |
| 486 | INDP | Indaptus Therapeutics, Inc. | 421.05M | 6.76% | 528,829 | - |
| 487 | SRTA | Strata Critical Medical, Inc. | 418.45M | 0.85% | 724,517 | 255.98M |
| 488 | ASMB | Assembly Biosciences, Inc. | 416.58M | -3.45% | 234,769 | 74.85M |
| 489 | SPRY | ARS Pharmaceuticals, Inc. | 415.19M | -2.68% | 1,010,607 | 116.93M |
| 490 | PRTA | Prothena Corporation plc | 412.24M | -5.53% | 461,392 | 54.53M |
| 491 | TRXB | TRex Bio, Inc. | 410.29M | 5.54% | 88,605 | - |
| 492 | YDES | YD Bio Limited | 408.70M | -1.20% | 144,054 | 1.24M |
| 493 | SI | Shoulder Innovations, Inc. | 402.64M | 3.31% | 154,742 | 60.06M |
| 494 | AUNA | Auna S.A. | 400.41M | -0.37% | 115,709 | 1.37B |
| 495 | OFIX | Orthofix Medical Inc. | 396.74M | -1.12% | 604,962 | 833.19M |
| 496 | ZURA | Zura Bio Limited | 395.77M | 3.25% | 4,187,809 | - |
| 497 | CARL | Carlsmed, Inc. | 390.70M | 0.92% | 129,324 | 63.30M |
| 498 | CCCC | C4 Therapeutics, Inc. | 389.99M | 0.32% | 2,080,420 | 35.04M |
| 499 | CTEV | Claritev Corporation | 389.79M | 2.72% | 117,618 | 994.67M |
| 500 | RZLT | Rezolute, Inc. | 388.12M | - | 929,975 | - |